This is the second of a two-part note, which covers: * What are GLP-1 receptor agonists? * Which were the first GLP-1s approved for type 2 diabetes (T2D)? When were they approved? Who makes them? Are ...

This is the first of a two-part note, which covers: * What are GLP-1 receptor agonists? * Which were the first GLP-1s approved for type 2 diabetes (T2D)? When were they approved? Who makes them? Are ...

Dr Shami graduated from Imperial College School of Medicine in London in 2000 and worked in the United Kingdom and New Zealand before settling in Melbourne. She has over 22 years of experience as a ...

Executive summary * A paper published in May 2025 used the Women's Health Initiative (WHI) population data in a novel way. It aimed to examine the impact of metformin vs sulfonylureas on exceptional ...